Deamino Arginine Vasopressin
"Deamino Arginine Vasopressin" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A synthetic analog of the pituitary hormone, ARGININE VASOPRESSIN. Its action is mediated by the VASOPRESSIN receptor V2. It has prolonged antidiuretic activity, but little pressor effects. It also modulates levels of circulating FACTOR VIII and VON WILLEBRAND FACTOR.
| Descriptor ID |
D003894
|
| MeSH Number(s) |
D06.472.699.631.692.781.100.250 D12.644.400.900.100.250 D12.644.456.925.100.250 D12.644.548.691.692.781.100.250 D12.776.631.650.937.100.250
|
| Concept/Terms |
Deamino Arginine Vasopressin- Deamino Arginine Vasopressin
- Arginine Vasopressin, Deamino
- 1-Desamino-8-arginine Vasopressin
- Vasopressin, 1-Desamino-8-arginine
- Desmopressin
- Vasopressin, Deamino Arginine
- 1-Deamino-8-D-arginine Vasopressin
- Vasopressin, 1-Deamino-8-D-arginine
DDAVP- DDAVP
- Octostim
- Desmotabs
- Octim
- Desmopressine Ferring
- Ferring, Desmopressine
- Desmospray
Desmopressin Acetate- Desmopressin Acetate
- Acetate, Desmopressin
- Desmopressin Monoacetate, Trihydrate
- Monoacetate, Trihydrate Desmopressin
- Trihydrate Desmopressin Monoacetate
|
Below are MeSH descriptors whose meaning is more general than "Deamino Arginine Vasopressin".
Below are MeSH descriptors whose meaning is more specific than "Deamino Arginine Vasopressin".
This graph shows the total number of publications written about "Deamino Arginine Vasopressin" by people in this website by year, and whether "Deamino Arginine Vasopressin" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1999 | 1 | 1 | 2 |
| 2013 | 0 | 1 | 1 |
| 2017 | 2 | 0 | 2 |
| 2018 | 1 | 1 | 2 |
| 2019 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Deamino Arginine Vasopressin" by people in Profiles.
-
Central diabetes insipidus (Infundibuloneuro hypophysitis): A late complication of COVID-19 infection. J Endocrinol Invest. 2021 Dec; 44(12):2855-2856.
-
ENDOCRINOLOGY IN THE TIME OF COVID-19: Management of diabetes insipidus and hyponatraemia. Eur J Endocrinol. 2020 Jul; 183(1):G9-G15.
-
Quantitative analysis of desmopressin (DDAVP) response in adult patients with type 1 von Willebrand disease. Int J Lab Hematol. 2019 Jun; 41(3):325-330.
-
von Willebrand factor clearance - biological mechanisms and clinical significance. Br J Haematol. 2018 10; 183(2):185-195.
-
Evaluation of recombinant factor VIIa, tranexamic acid and desmopressin to reduce prasugrel-related bleeding: A randomised, placebo-controlled study in a rabbit model. Eur J Anaesthesiol. 2018 03; 35(3):208-214.
-
Low-Dose Desmopressin Nasal Spray and FDA Approval-Reply. JAMA. 2017 09 19; 318(11):1071-1072.
-
FDA Approval of Desmopressin for Nocturia. JAMA. 2017 05 23; 317(20):2059-2060.
-
Central diabetes insipidus in pediatric severe traumatic brain injury. Pediatr Crit Care Med. 2013 Feb; 14(2):203-9.
-
A combination of prednisone, high-dose intravenous immunoglobulin and desmopressin in the treatment of acquired hemophilia A with high-titer inhibitor. Haematologica. 1999 Nov; 84(11):1054.
-
A longitudinal study of vasopressin cell antibodies, posterior pituitary function, and magnetic resonance imaging evaluations in subclinical autoimmune central diabetes insipidus. J Clin Endocrinol Metab. 1999 Sep; 84(9):3047-51.